316 related articles for article (PubMed ID: 14985865)
1. Technetium-99m sestamibi brain SPECT in the follow-up of glioma for evaluation of response to chemotherapy: first results.
Prigent-Le Jeune F; Dubois F; Perez S; Blond S; Steinling M
Eur J Nucl Med Mol Imaging; 2004 May; 31(5):714-9. PubMed ID: 14985865
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-MIBI brain SPECT as an indicator of the chemotherapy response of recurrent, primary brain tumors.
Bleichner-Perez S; Le Jeune F; Dubois F; Steinling M
Nucl Med Commun; 2007 Dec; 28(12):888-94. PubMed ID: 18090213
[TBL] [Abstract][Full Text] [Related]
3. [Evaluation for degree of malignancy and prognosis of patients with brain glioma using 99Tcm-MIBI brain SPECT].
Fan YX; Luo RC; Li GP; Zheng H; Huang K
Ai Zheng; 2004 Jun; 23(6):689-92. PubMed ID: 15191672
[TBL] [Abstract][Full Text] [Related]
4. 99mTc-sestamibi brain SPECT after chemoradiotherapy is prognostic of survival in patients with high-grade glioma.
Beauchesne P; Pedeux R; Boniol M; Soler C
J Nucl Med; 2004 Mar; 45(3):409-13. PubMed ID: 15001680
[TBL] [Abstract][Full Text] [Related]
5. Sestamibi technetium-99m brain single-photon emission computed tomography to identify recurrent glioma in adults: 201 studies.
Le Jeune FP; Dubois F; Blond S; Steinling M
J Neurooncol; 2006 Apr; 77(2):177-83. PubMed ID: 16314957
[TBL] [Abstract][Full Text] [Related]
6. Technetium-99m sestamibi brain single-photon emission tomography for detection of recurrent gliomas after radiation therapy.
Soler C; Beauchesne P; Maatougui K; Schmitt T; Barral FG; Michel D; Dubois F; Brunon J
Eur J Nucl Med; 1998 Dec; 25(12):1649-57. PubMed ID: 9871097
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m MIBI SPECT in prediction of prognosis in patients with small cell lung cancer.
Akgun A; Cok G; Karapolat I; Goksel T; Burak Z
Ann Nucl Med; 2006 May; 20(4):269-75. PubMed ID: 16856570
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of pediatric CNS malignancies with (99m)Tc-methoxyisobutylisonitrile SPECT.
Kirton A; Kloiber R; Rigel J; Wolff J
J Nucl Med; 2002 Nov; 43(11):1438-43. PubMed ID: 12411545
[TBL] [Abstract][Full Text] [Related]
9. Introduction of novel semiquantitative evaluation of (99m)Tc-MIBI SPECT before and after treatment of glioma.
Deltuva VP; Jurkienė N; Kulakienė I; Bunevičius A; Matukevičius A; Tamašauskas A
Medicina (Kaunas); 2012; 48(1):15-21. PubMed ID: 22481370
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic value of 99mTc-MIBI brain SPECT for brain glioma].
Fan YX; Luo RC; Li GP; Huang K
Di Yi Jun Yi Da Xue Xue Bao; 2004 Oct; 24(10):1184-5. PubMed ID: 15485796
[TBL] [Abstract][Full Text] [Related]
11. Correlation of 99mTc-MIBI brain spect (functional index ratios) and survival after treatment failure in malignant glioma patients.
Beauchesne P; Soler C
Anticancer Res; 2002; 22(5):3081-5. PubMed ID: 12530047
[TBL] [Abstract][Full Text] [Related]
12. A new semiquantitative method for comparing brain tumor uptake of Tc-99m sestamibi and TI-201.
San Pedro EC; Yilmaz M; Liu HG; Rosenfeld SS; Mountz JM
Clin Nucl Med; 1999 Nov; 24(11):868-73. PubMed ID: 10551470
[TBL] [Abstract][Full Text] [Related]
13. Technetium-99m-labelled HL91 and technetium-99m-labelled MIBI SPECT imaging for the detection of ischaemic viable myocardium: a preliminary study.
Liu M; Ma Z; Guo X; Zhu J; Su J
Clin Physiol Funct Imaging; 2012 Jan; 32(1):25-32. PubMed ID: 22152075
[TBL] [Abstract][Full Text] [Related]
14. Application of SPET using technetium-99m sestamibi in brain tumours and comparison with expression of the MDR-1 gene: is it possible to predict the response to chemotherapy in patients with gliomas by means of 99mTc-sestamibi SPET?
Yokogami K; Kawano H; Moriyama T; Uehara H; Sameshima T; Oku T; Goya T; Wakisaka S; Nagamachi S; Jinnouchi S; Tamura S
Eur J Nucl Med; 1998 Apr; 25(4):401-9. PubMed ID: 9553170
[TBL] [Abstract][Full Text] [Related]
15. Delineation of target volume for radiotherapy of high-grade gliomas by 99m Tc-MIBI SPECT and MRI fusion.
Krengli M; Loi G; Sacchetti G; Manfredda I; Gambaro G; Brambilla M; Carriero A; Inglese E
Strahlenther Onkol; 2007 Dec; 183(12):689-94. PubMed ID: 18040614
[TBL] [Abstract][Full Text] [Related]
16. Direct comparison of thallium-201 and technetium-99m MIBI SPECT of a glioma by receiver operating characteristic analysis.
Shibata Y; Yamamoto T; Takano S; Katayama W; Takeda T; Matsumura A
J Clin Neurosci; 2009 Feb; 16(2):264-9. PubMed ID: 19084414
[TBL] [Abstract][Full Text] [Related]
17. Usefulness of chest single photon emission computed tomography with technetium-99m methoxyisobutylisonitrile to predict taxol based chemotherapy response in advanced non-small cell lung cancer.
Shih CM; Hsu WH; Huang WT; Wang JJ; Ho ST; Kao A
Cancer Lett; 2003 Sep; 199(1):99-105. PubMed ID: 12963129
[TBL] [Abstract][Full Text] [Related]
18. Assessment of 99mTc-MIBI SPECT(/CT) to monitor multidrug resistance-related proteins and apoptosis-related proteins in patients with ovarian cancer: a preliminary study.
Kurata S; Ushijima K; Kawahara A; Kaida H; Kawano K; Hirose Y; Kage M; Kamura T; Ishibashi M; Abe T
Ann Nucl Med; 2015 Aug; 29(7):643-9. PubMed ID: 25921216
[TBL] [Abstract][Full Text] [Related]
19. Quickly predicting chemotherapy response to paclitaxel-based therapy in non-small cell lung cancer by early technetium-99m methoxyisobutylisonitrile chest single-photon-emission computed tomography.
Kao CH; Hsieh JF; Tsai SC; Ho YJ; Lee JK
Clin Cancer Res; 2000 Mar; 6(3):820-4. PubMed ID: 10741702
[TBL] [Abstract][Full Text] [Related]
20. Value of 99m Tc-MIBI SPECT/CT in the localization of recurrent lesions in patients with suspected recurrent parathyroid carcinoma.
Guo YH; Huang JW; Wang Y; Lu R; Yang MF
Nucl Med Commun; 2023 Jan; 44(1):18-26. PubMed ID: 36437540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
